Sarkis Meterissian

Sarkis Meterissian appears in our data through filings on Defence Therapeutics Inc. shares, published by SEDI. In total, 5 filings cover trades dated from 30 April 2021 to 21 December 2023.

No open-market purchase appears, only 2 sales worth €15k. The rest of the record consists of 2 option exercises. In 2023 alone, the filings show no purchases and 2 sales.

The latest filing, published on 22 December 2023, reports an option exercise of €85k in Defence Therapeutics Inc. The median gap between a trade and its publication by SEDI is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEDI disclosures alone and does not predict where the share price will go.